Results 221 to 230 of about 160,488 (298)

Integrative Clinical and Molecular Evaluation of Renal Cell Carcinoma with Merlin Protein Deficiency and Biallelic Loss of NF2. [PDF]

open access: yesClin Cancer Res
Yekedüz E   +18 more
europepmc   +1 more source

Seasonal Predictions and Their Applications in the Mediterranean Region: Part II—Prediction‐Based Services

open access: yesInternational Journal of Climatology, Volume 46, Issue 6, May 2026.
This review explores climate predictions as actionable decision‐making tools, focusing on the Mediterranean. It examines transforming forecasts into user‐defined information through bias adjustment, downscaling and impact models. Highlighting collaborative EU initiatives, it addresses challenges like limited forecasting skill and data accessibility ...
Silvio Gualdi   +12 more
wiley   +1 more source

When Refractory Is Not the End: Redefining Chronic Cough Through Tertiary Center Evaluation. [PDF]

open access: yesMayo Clin Proc Innov Qual Outcomes
Ahmad SR   +7 more
europepmc   +1 more source

Lower Plasma Antioxidant Defense and Heat Shock Proteins Mark Intra‐Amniotic Sludge Ultrasound Finding

open access: yesJournal of Ultrasound in Medicine, Volume 45, Issue 5, Page 1083-1094, May 2026.
Objectives Intra‐amniotic sludge is an independent risk factor for preterm birth. It consists of a biophysical sonographic finding in the amniotic fluid, formed by dense echogenic particles near the cervical internal orifice, due to sterile or infectious inflammatory processes.
Clarissa Chavez Ortiz Roberto   +8 more
wiley   +1 more source

Epithelial-mesenchymal transition and sunitinib resistance in renal cell carcinoma: mechanisms and therapeutic strategies. [PDF]

open access: yesFront Pharmacol
Zhang M   +9 more
europepmc   +1 more source

Nonclassical MHC‐I Molecules: Emerging Therapeutic Targets in Next‐Generation Immunotherapy

open access: yesMedComm, Volume 7, Issue 5, May 2026.
Immunotherapies dependent on classical MHC‐I molecules face significant challenges, including extreme polymorphism and frequent downregulation in pathological conditions. This review discusses how nonclassical MHC‐I molecules (HLA‐E, HLA‐F, HLA‐G, CD1, MR1) may potentially circumvent these limitations through restricted genetic diversity, stable ...
Wanlin He, Andrew J. McMichael
wiley   +1 more source

Targeting Tumor Stroma: Current Challenges and Future Directions

open access: yesMedComm, Volume 7, Issue 5, May 2026.
Figure 1. Mechanism of ECM reprogramming. Cancer‐associated fibroblasts (CAFs), cancer‐associated macrophages (CAMs), and other mesenchymal cells alter the ECM composition and increase its stiffness by depositing matrix components such as collagen and hyaluronic acid, and secreting cross‐linking agents like lysyl oxidase homolog 2 (LOXL2).
Siwei Wang   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy